Reata Pharmaceuticals, Inc. (RETA) has 20 known insider and institutional holders on record. The largest holder is Novo Holdings A/S with 1,201,969 shares. Other notable holders include AbbVie Inc. and Novo A/S.
RETA Insider Ownership
Top Holder
Novo Holdings A/S
1,201,969 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Novo Holdings A/s |
10 Percent Owner |
1,201,969 |
2017-06-23 |
|
| 2 |
Abbvie Inc. |
10 Percent Owner |
1,190,473 |
2017-03-30 |
|
| 3 |
Novo A/s |
10 Percent Owner |
642,405 |
2017-06-14 |
|
| 4 |
Meyer Colin John |
Chief Innovation Officer |
82,229 |
2023-08-17 |
|
| 5 |
Soni Manmeet Singh |
COO, CFO and President |
62,621 |
2023-08-17 |
|
| 6 |
Wortley Michael D |
Chief Legal Officer |
50,099 |
2023-08-17 |
|
| 7 |
Huff James Warren |
Chief Executive Officer |
49,916 |
2023-07-10 |
|
| 8 |
Traweek James W Jr |
Officer |
46,645 |
2020-01-02 |
|
| 9 |
Patni Rajiv |
EVP, Chief R&d Officer |
45,000 |
2023-06-14 |
|
| 10 |
Khan Samina |
SVP, Chief Medical Officer |
39,843 |
2023-05-17 |
|
| 11 |
Bir Dawn Carter |
Chief Commercial Officer |
34,203 |
2023-08-17 |
|
| 12 |
Rose William |
Director |
29,000 |
2023-09-19 |
|
| 13 |
Loewen Andrea |
SVP, Global Regulatory Affairs |
28,416 |
2023-09-18 |
|
| 14 |
Anand Bhaskar |
SVP, Chief Accounting Officer |
24,089 |
2023-09-07 |
|
| 15 |
Wilson Jason Douglas |
Executive VP of Operations |
15,000 |
2020-01-06 |
|
| 16 |
Ward Keith Wayne |
Chief Development Officer |
8,620 |
2019-02-27 |
|
| 17 |
Stone Dennis K. |
Director |
6,000 |
2016-12-08 |
|
| 18 |
Cpmg Inc |
Officer |
5,464 |
2019-11-18 |
|
| 19 |
Oliger Christy J. |
Director |
2,137 |
2023-06-09 |
|
| 20 |
Mcgaughy R Kent Jr |
10 Percent Owner |
1,628 |
2023-06-09 |
|
No ownership data available for RETA.
